Access for All: The Realities of Enhancing Care and Treatment in Africa
Sunday, July 11, 2004 –11.45 – 16.00
Room F, IMPACT Convention Centre Muang Thong Thani, Nonthaburi, Thailand
The satellite symposium highlighted critical concerns surrounding the implementation of HIV care and treatment programs in Africa.
Program
11:45AM – 11:55AM Introduction
Max Essex, D.V.M., Ph.D., Mary Woodard Lasker Professor of Health Sciences, Harvard School of Public Health, Chair, Harvard School of Public Health AIDS Initiative, Boston, MA, USA
11:55AM – 12:40PM Uptake of Voluntary Counseling and Testing
1. How can potential access to antiretroviral therapy affect uptake of VCT?
2. What mechanisms have proven successful to get people to use VCT services?
3. What are the new paradigms for more routine testing for HIV infection?
Chair: Kenneth McIntosh, M.D., Professor, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA
Phyllis Kanki, S.D., D.V.M., Professor, Immunology and Infectious Diseases, Harvard School of Public Health, Director, AIDS Prevention Initiative Nigeria, Boston, MA, USA
Gernard Msamanga, M.D., Sc.D., Associate Professor of Community Health, Muhimbili University College of Health Sciences, Dar es Salaam, Tanzania
Discussion – 20 minutes
12:40 – 1:45PM Key Concerns: Training, Infrastructure & Evaluation
1. What are the effective models for training physicians and healthcare workers? What type of curricula is needed?
2. How are monitoring and evaluation of different kinds of treatment conducted in different settings?
3. What are the necessary components for an effective infrastructure?
Chair: Olusoji Adeyi, Ph.D., MCommH, M.B.B.S., Coordinator, Global Partnerships for Communicable Diseases, Human Development Network, The World Bank, Washington, DC, USA
Richard Marlink, M.D., Research Director, Harvard School of Public Health AIDS Initiative, Scientific Director – Care and Treatment, Elizabeth Glaser Pediatric AIDS Foundation, Harvard School of Public Health, Boston, MA, USA
Rob Murphy, M.D., Professor, Division of Infectious Diseases, Northwestern University, Chicago, IL, USA
Souleymane Mboup, Ph.D., Professor and Chief, Bacteriology and Virology Laboratory, Universite Cheikh Anta Diop, CHU Le Dantec, Pharmacien Commandant, Health Military School of Dakar, Dakar, Senegal
Saidi Kapiga, M.D, M.P.H, Sc.D., Assistant Professor of Reproductive Health, Harvard School of Public Health, Boston, MA, USA
Discussion – 20 minutes
1:45 – 1:55PM Break
1:55 – 2:50PM Realities of Scaling Up Care and Treatment: Challenges and Opportunities
1. What are the long-term requirements for enhancing care and treatment? {e.g. financial, technical, human, political commitment, etc.}
Chair: Sofia Gruskin, J.D., M.I.A., Director, Program on International Health and Human Rights, François-Xavier Bagnoud Center for Health and Human Rights, Associate Professor on Health and Human Rights, Department of Population and International Health, Harvard School of Public Health, Boston, MA, USA
Ernest Ekong, M.D., Research Clinician/Public Health Physician, Nigeria HIV/AIDS Research Network, Department of Medicine, Nigerian Army Reference Hospital, Yaba, Lagos, Nigeria
Patson Mazonde, Deputy Permanent Secretary of Health, Director of Health Services, Ministry of Health, Gaborone, Bostwana
Papa Salif Sow, M.D., Professor of Medicine, Dakar University Teaching Hospital, Department of Infectious Diseases, Fann Hospital, Dakar, Senegal
Discussion – 20 minutes
2:50 – 3:50PM Models of Care and Treatment
1. What are the successful models of scaling up care and treatment?
2. How do you enhance care for people living with HIV?
3. What are the protocols for people not meeting the AIDS definition?
4. Problems of mixing use of the same drugs (&/or classes) for PMTCT and HAART in the same populations?
Chair: TBC
John Idoko, M.D., Professor of Medicine, University of Jos, Department of Medicine, Jos University Teaching Hospital, Jos, Plateau State, Nigeria
Marc Lallemant, M.D., Research Director, Organization Institut de Recherche our le Développement, Perinatal HIV Prevention Trial, Thailand, Muang, Chiang Mai, Thailand
Ferdinand Mugusi, M.D., Mmed, Senior Lecturer and Chair, Department of Internal Medicine, Muhimbili University College of Health Sciences, Dar es Salaam, Tanzania
Ndwapi Ndwapi, M.D., Co-Director, Infectious Disease Care Clinic, Princess Marina Hospital, Gaborone, Botswana
Discussion – 20 minutes
3:50 – 4:00PM Conclusion
Max Essex, D.V.M., Ph.D., Mary Woodard Lasker Professor of Health Sciences, Harvard School of Public Health, Chair, Harvard School of Public Health AIDS Initiative, Boston, MA, USA
Refreshments will be provided.
Sponsored by the Harvard School of Public Health AIDS Initiative and the AIDS Prevention Initiative Nigeria.
|
|
